AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32114699 — intervention group
Group type: EXPERIMENTAL
Intervention: Interprofessional education through case-based learning sessions
Number of subjects: 113
Study 32114699 — intervention group
Group type: COMPARATOR
Intervention: Control group (no interprofessional education)
Number of subjects: 113
Study 32114699 — intervention group
Group type: EXPERIMENTAL
Intervention: Interprofessional education
Number of subjects: 113
Study 35312376 — intervention group
Group type: EXPERIMENTAL
Intervention: 2D radiomics model
Number of subjects: 172
Study 35312376 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D radiomics model
Number of subjects: 172
Study 35312376 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated nomogram
Number of subjects: 172
Study 33712274 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (bev)
Number of subjects: 1249
Study 33712274 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1249
Study 33560501 — intervention group
Group type: EXPERIMENTAL
Intervention: Keyhole technique
Number of subjects: 235
Study 33560501 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugarbaker technique
Number of subjects: 235
Study 33560501 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandwich technique
Number of subjects: 235
Study 33560501 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific intra-abdominal keyhole technique with funnel-shaped mesh
Number of subjects: 235
Study 33560501 — intervention group
Group type: EXPERIMENTAL
Intervention: Other techniques
Number of subjects: 235
Study 33560501 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 235
Study 35101724 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal usual care plus neurodynamic intervention
Number of subjects: 32
Study 35101724 — intervention group
Group type: COMPARATOR
Intervention: Multimodal usual care alone
Number of subjects: 32
Study 34011203 — intervention group
Group type: EXPERIMENTAL
Intervention: BSS at 2.7°C (Group 2)
Number of subjects: 214
Study 34011203 — intervention group
Group type: COMPARATOR
Intervention: BSS at operating room temperature (Group 1)
Number of subjects: 214
Study 32045773 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) 1.5 g intra-articular combined with 1.5 g intravenous
Number of subjects: 74
Study 32045773 — intervention group
Group type: COMPARATOR
Intervention: Hemocoagulase atrox 1 U intra-articular combined with 1 U intravenous
Number of subjects: 74
Study 32045773 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 74
Study 32045773 — intervention group
Group type: COMPARATOR
Intervention: Hemocoagulase atrox
Number of subjects: 74
Study 32045773 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 74
Study 34049378 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous somatostatin plus rectal indomethacin (100 mg suppository)
Number of subjects: 376
Study 34049378 — intervention group
Group type: COMPARATOR
Intervention: Control group (rectal indomethacin only)
Number of subjects: 376
Study 33499257 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet - fish and seafood consumption
Number of subjects: 479
Study 33499257 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 479
Study 33499257 — intervention group
Group type: EXPERIMENTAL
Intervention: Overweight and obesity
Number of subjects: 479
Study 33499257 — intervention group
Group type: EXPERIMENTAL
Intervention: High educational level and older age
Number of subjects: 479
Study 33499257 — intervention group
Group type: EXPERIMENTAL
Intervention: Saturated fatty acids (SFA) and monounsaturated fatty acids (MUFA)
Number of subjects: 479
Study 35392995 — intervention group
Group type: EXPERIMENTAL
Intervention: quetiapine (n = 71)
Number of subjects: 121
Study 35392995 — intervention group
Group type: EXPERIMENTAL
Intervention: lithium (n = 50)
Number of subjects: 121
Study 33930244 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic hepatitis B (CHB) patients
Number of subjects: 30
Study 35134142 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-osteoperforations (MOPs) - two 5 mm deep MOPs performed prior to space closure
Number of subjects: 20
Study 35134142 — intervention group
Group type: COMPARATOR
Intervention: Control - no MOPs applied
Number of subjects: 20
Study 34374960 — intervention group
Group type: EXPERIMENTAL
Intervention: vNOTES hysterectomy
Number of subjects: 26
Study 34374960 — intervention group
Group type: COMPARATOR
Intervention: LESS hysterectomy
Number of subjects: 26
Study 32577819 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 77
Study 32577819 — intervention group
Group type: COMPARATOR
Intervention: VKA
Number of subjects: 77
Study 34647708 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodenal-Jejunal Bypass Liner (DJBL)
Number of subjects: 170
Study 34647708 — intervention group
Group type: COMPARATOR
Intervention: Control (intensive medical care without DJBL)
Number of subjects: 170
Study 33148224 — intervention group
Group type: COMPARATOR
Intervention: Urban residence
Number of subjects: 1157
Study 33148224 — intervention group
Group type: COMPARATOR
Intervention: Rural residence
Number of subjects: 1157
Study 33148224 — intervention group
Group type: COMPARATOR
Intervention: Participants aged below 14 years
Number of subjects: 1157
Study 33148224 — intervention group
Group type: COMPARATOR
Intervention: Participants with both parents alive
Number of subjects: 1157
Study 33148224 — intervention group
Group type: COMPARATOR
Intervention: Participants whose fathers had skilled occupations
Number of subjects: 1157
Study 33148224 — intervention group
Group type: COMPARATOR
Intervention: Participants who watched TV every day
Number of subjects: 1157
Study 33148224 — intervention group
Group type: COMPARATOR
Intervention: Rural participants
Number of subjects: 1157
Study 33148224 — intervention group
Group type: COMPARATOR
Intervention: Urban participants
Number of subjects: 1157
Study 33148224 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall knowledge comparison
Number of subjects: 1157
Study 33148224 — intervention group
Group type: EXPERIMENTAL
Intervention: Age at menarche over the last two decades
Number of subjects: 1157
Study 35881014 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortical allograft
Number of subjects: 120
Study 35881014 — intervention group
Group type: COMPARATOR
Intervention: PEEK interbody spacers
Number of subjects: 120
Study 35881014 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study 33260247 — intervention group
Group type: EXPERIMENTAL
Intervention: Abemaciclib
Number of subjects: 1
Study 32460818 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ciprofloxacin and co-amoxiclav for at least 5 days after switching from intravenous antibiotics within 12-24 hours of starting IV therapy.
Number of subjects: 230
Study 32460818 — intervention group
Group type: COMPARATOR
Intervention: Intravenous antibiotics (piperacillin/tazobactam or meropenem) continued for at least 48 hours.
Number of subjects: 230
Study 35435878 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical Massage (CM)
Number of subjects: 72
Study 35435878 — intervention group
Group type: EXPERIMENTAL
Intervention: Benson Relaxation Exercise (BRE)
Number of subjects: 72
Study 35435878 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 72
Study 34379375 — intervention group
Group type: EXPERIMENTAL
Intervention: Static Stretching (SS)
Number of subjects: 14
Study 34379375 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Stretching (DS)
Number of subjects: 14
Study 34379375 — intervention group
Group type: COMPARATOR
Intervention: Myofascial Foam Rolling (FR)
Number of subjects: 14
Study 33327334 — intervention group
Group type: EXPERIMENTAL
Intervention: SVV-guided fluid management
Number of subjects: 60
Study 33327334 — intervention group
Group type: COMPARATOR
Intervention: Conventional fluid therapy
Number of subjects: 60
Study 36333665 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain intensity measured on a 0-100 scale
Number of subjects: 12
Study 36333665 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain intensity measured on a 0-10 scale
Number of subjects: 12
Study 36333665 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain intensity measured on a 0-3 scale
Number of subjects: 12
Study 36333665 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain intensity measured on a 0-4 scale
Number of subjects: 12
Study 33582852 — intervention group
Group type: EXPERIMENTAL
Intervention: Submucous resection (group A, n = 45)
Number of subjects: 90
Study 33582852 — intervention group
Group type: COMPARATOR
Intervention: Combined submucous diathermy and outfracture (group B, n = 45)
Number of subjects: 90
Study 32378802 — intervention group
Group type: EXPERIMENTAL
Intervention: Common hepatic duct clamping using atraumatic bulldog clamp after biliary division (Group I)
Number of subjects: 40
Study 32378802 — intervention group
Group type: COMPARATOR
Intervention: No clamping (Group II)
Number of subjects: 40
Study 32378802 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 40
Study 35003796 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (trochlear dysplasia model)
Number of subjects: 120
Study 35003796 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 33332313 — intervention group
Group type: EXPERIMENTAL
Intervention: Florida Sleeve technique (FS group)
Number of subjects: 64
Study 33332313 — intervention group
Group type: COMPARATOR
Intervention: David technique (D group)
Number of subjects: 64
Study 34372752 — intervention group
Group type: EXPERIMENTAL
Intervention: High repetition arm training (6 sessions between 3 and 6 weeks)
Number of subjects: 36
Study 34372752 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 36
Study 33688946 — intervention group
Group type: EXPERIMENTAL
Intervention: [18F]fluorodeoxyglucose (FDG) PET‐CT and endoscopic ultrasonography (EUS) with guided fine‐needle aspiration biopsy
Number of subjects: 89
Study 33688946 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS
Number of subjects: 89
Study 33688946 — intervention group
Group type: EXPERIMENTAL
Intervention: PET‐CT
Number of subjects: 89
Study 33688946 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard follow-up visits)
Number of subjects: 89
Study 36344005 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive oxygen strategy (lowest dosage of oxygen >21% to ensure SpO2 of 94%)
Number of subjects: 1420
Study 36344005 — intervention group
Group type: COMPARATOR
Intervention: Liberal oxygen strategy (12-15 L O2/min or FiO2 = 0.6-1.0)
Number of subjects: 1420
Study 32967392 — intervention group
Group type: EXPERIMENTAL
Intervention: Scrambler Therapy (ST)
Number of subjects: 80
Study 32967392 — intervention group
Group type: COMPARATOR
Intervention: Control (standard pain management drugs)
Number of subjects: 80
Study 35241690 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral verapamil
Number of subjects: 0
Study 32059974 — intervention group
Group type: EXPERIMENTAL
Intervention: ARM + ve preservation ALND
Number of subjects: 98
Study 32059974 — intervention group
Group type: COMPARATOR
Intervention: Conventional ALND
Number of subjects: 98
Study 35988198 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment + BAL
Number of subjects: 40
Study 35988198 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment + ST + BAL
Number of subjects: 40
Study 35988198 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment + ST
Number of subjects: 40
Study 34949968 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive nursing intervention (MHD group)
Number of subjects: 100
Study 34949968 — intervention group
Group type: COMPARATOR
Intervention: Traditional nursing service (routine group)
Number of subjects: 100
Study 33370739 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese music therapy
Number of subjects: 120
Study 33370739 — intervention group
Group type: COMPARATOR
Intervention: Painting therapy
Number of subjects: 120
Study 33370739 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment
Number of subjects: 120
Study 35677742 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional osteoporosis risk factors
Number of subjects: 135
Study 35677742 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 135
Study 35677742 — intervention group
Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 135
Study 35677742 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous fracture
Number of subjects: 135
Study 35677742 — intervention group
Group type: EXPERIMENTAL
Intervention: Asian race
Number of subjects: 135
Study 35677742 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D therapy requirement
Number of subjects: 135
Study 35677742 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c
Number of subjects: 135
Study 35677742 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior cardiovascular event
Number of subjects: 135
Study 35677742 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum albumin
Number of subjects: 135
Study 32655047 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary counseling
Number of subjects: 87
Study 35099543 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label placebo (OLP) for 3 weeks
Number of subjects: 30
Study 35099543 — intervention group
Group type: COMPARATOR
Intervention: Control period for 3 weeks
Number of subjects: 30
Study 36058207 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced Hybrid Closed Loop (AHCL) therapy
Number of subjects: 82
Study 36058207 — intervention group
Group type: COMPARATOR
Intervention: Multiple daily injections of insulin plus isCGM
Number of subjects: 82
Study 36058207 — intervention group
Group type: EXPERIMENTAL
Intervention: AHCL group
Number of subjects: 82
Study 36058207 — intervention group
Group type: COMPARATOR
Intervention: Multiple daily injections of insulin plus isCGM group
Number of subjects: 82
Study 33350891 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-based synthetic CT (sCT)
Number of subjects: 30
Study 33350891 — intervention group
Group type: COMPARATOR
Intervention: T1-weighted MRI
Number of subjects: 30
Study 36395746 — intervention group
Group type: EXPERIMENTAL
Intervention: Killed oral cholera vaccine (OCV) with a second dose after 2 weeks
Number of subjects: 186
Study 36395746 — intervention group
Group type: EXPERIMENTAL
Intervention: Killed oral cholera vaccine (OCV) with a second dose after 6 months
Number of subjects: 186
Study 36395746 — intervention group
Group type: EXPERIMENTAL
Intervention: Killed oral cholera vaccine (OCV) with a second dose after 11.5 months
Number of subjects: 186
Study 35360485 — intervention group
Group type: COMPARATOR
Intervention: Sodium hyaluronate eye drops (Control)
Number of subjects: 92
Study 34209004 — intervention group
Group type: EXPERIMENTAL
Intervention: Suspension training (n = 12)
Number of subjects: 36
Study 34209004 — intervention group
Group type: COMPARATOR
Intervention: Traditional training (n = 13)
Number of subjects: 36
Study 34209004 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise control group (n = 11)
Number of subjects: 36
Study 34504284 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS (20 Hz, 1800 pulses per session) for 4 weeks before lower limb resistance training or physical therapy
Number of subjects: 20
Study 34504284 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 20
Study 34504284 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS
Number of subjects: 20
Study 33475984 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual fentanyl tablet
Number of subjects: 100
Study 33475984 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 33754424 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine HCl (5.0 mg/mL) mixed with isotonic solution (4, 6, 8, and 10 mL of levobupivacaine with 26, 24, 22, and 20 mL of isotonic solution, respectively)
Number of subjects: 100
Study 33754424 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine HCl (5.0 mg/mL) mixed with isotonic solution
Number of subjects: 100
Study 33754424 — intervention group
Group type: COMPARATOR
Intervention: Control group using Cathejell-2% lidocaine (25 mg lidocaine)
Number of subjects: 100
Study 32565123 — intervention group
Group type: EXPERIMENTAL
Intervention: Swimming
Number of subjects: 32
Study 32565123 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling
Number of subjects: 32
Study 32565123 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 32
Study 32409696 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of PR interval
Number of subjects: 1722
Study 32409696 — intervention group
Group type: EXPERIMENTAL
Intervention: CAV1 SNP
Number of subjects: 1722
Study 32409696 — intervention group
Group type: EXPERIMENTAL
Intervention: CAV1 SNP (Mendelian randomization)
Number of subjects: 1722
Study 33830082 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibition of miR-122 in the lung
Number of subjects: 87
Study 33830082 — intervention group
Group type: COMPARATOR
Intervention: Higher miR-122 expression in nasopharyngeal aspirates
Number of subjects: 87
Study 33645399 — intervention group
Group type: EXPERIMENTAL
Intervention: LASER Artificial Shrinkage (LAS)
Number of subjects: 409
Study 33645399 — intervention group
Group type: COMPARATOR
Intervention: Micro-Needle Artificial Shrinkage (MNAS)
Number of subjects: 409
Study 34102783 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal glucocorticoid (dexamethasone) after nasal endoscopic surgery
Number of subjects: 122
Study 34102783 — intervention group
Group type: COMPARATOR
Intervention: Oral glucocorticoid (prednisone) one week before operation and three weeks after operation
Number of subjects: 122
Study 35322424 — intervention group
Group type: COMPARATOR
Intervention: Traditional conclusion scale
Number of subjects: 60
Study 35322424 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength-of-support conclusion scale
Number of subjects: 60
Study 35322424 — intervention group
Group type: EXPERIMENTAL
Intervention: Expanded scale
Number of subjects: 60
Study 32890339 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A emergency-release plasma (ERP)
Number of subjects: 584
Study 32890339 — intervention group
Group type: COMPARATOR
Intervention: Group AB emergency-release plasma (ERP)
Number of subjects: 584
Study 32890339 — intervention group
Group type: EXPERIMENTAL
Intervention: Incompatible ERP (group B or AB patients receiving group A ERP)
Number of subjects: 584
Study 32207667 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Check Up (FCU)
Number of subjects: 102
Study 32207667 — intervention group
Group type: COMPARATOR
Intervention: Brief Psychoeducation (PE)
Number of subjects: 102
Study 34503552 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous hematopoietic stem cell transplant (AHSCT) treatment
Number of subjects: 278
Study 34503552 — intervention group
Group type: EXPERIMENTAL
Intervention: Modifiable factors (distance to treatment center and cost)
Number of subjects: 278
Study 34503552 — intervention group
Group type: EXPERIMENTAL
Intervention: Predicted recruitment rates
Number of subjects: 278
Study 36030986 — intervention group
Group type: EXPERIMENTAL
Intervention: Osc+ condition (biofeedback to increase heart rate oscillations)
Number of subjects: 0
Study 36030986 — intervention group
Group type: COMPARATOR
Intervention: Osc− condition (biofeedback to decrease heart rate oscillations)
Number of subjects: 0
Study 33874838 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to music during warm-up after partial sleep deprivation (PSD)
Number of subjects: 12
Study 33874838 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to music during warm-up after normal sleep nights (NSN)
Number of subjects: 12
Study 33874838 — intervention group
Group type: COMPARATOR
Intervention: Partial sleep deprivation (PSD)
Number of subjects: 12
Study 36145115 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g of ground raw golden flaxseed
Number of subjects: 19
Study 36145115 — intervention group
Group type: COMPARATOR
Intervention: Standardized breakfast without flaxseed (control)
Number of subjects: 19
Study 33334807 — intervention group
Group type: COMPARATOR
Intervention: CGM+FBI
Number of subjects: 143
Study 33334807 — intervention group
Group type: COMPARATOR
Intervention: Standard‐CGM
Number of subjects: 143
Study 33334807 — intervention group
Group type: COMPARATOR
Intervention: BGM
Number of subjects: 143
Study 33334807 — intervention group
Group type: COMPARATOR
Intervention: CGM+FBI parents
Number of subjects: 143
Study 34894724 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 80
Study 34894724 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 32056864 — intervention group
Group type: EXPERIMENTAL
Intervention: PROMIS depression scales
Number of subjects: 651
Study 33120302 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 182
Study 33120302 — intervention group
Group type: COMPARATOR
Intervention: Ketamine
Number of subjects: 182
Study 33120302 — intervention group
Group type: COMPARATOR
Intervention: Combination of haloperidol and ketamine
Number of subjects: 182
Study 33120302 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 182
Study 33120302 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative cortisol levels
Number of subjects: 182
Study 33120302 — intervention group
Group type: EXPERIMENTAL
Intervention: S-100β levels
Number of subjects: 182
Study 33120302 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative NSE levels
Number of subjects: 182
Study 32344198 — intervention group
Group type: EXPERIMENTAL
Intervention: Ileo-colonic delivery of conjugated bile acids (IC-CBAS)
Number of subjects: 307
Study 32344198 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 307
Study 36497548 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component exercise (MCE)
Number of subjects: 24
Study 36497548 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 34170389 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegaspargase (3000 IU/m2 IV) during induction
Number of subjects: 482
Study 34170389 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegaspargase (2500 IU/m2 or 3500 IU/m2 IV intermittently)
Number of subjects: 482
Study 34170389 — intervention group
Group type: COMPARATOR
Intervention: Pegaspargase vs Erwinase
Number of subjects: 482
Study 34170389 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum asparaginase activity
Number of subjects: 482